Why Investors are Pushing Into Psychedelic Stocks
Psilocybin has made major headlines over the last few days. Not only was it legalized in Oregon and Washington, D.C.,
Read more
Healthcare
Health Issue Could Impact 5G Boom
The 5G boom could usher in a potential $12 trillion opportunity benefiting companies like Apple Inc. (NASDAQ:AAPL), Qualcomm Inc. (NASDAQ:QCOM),
Read more
Testing Economy a $157 Billion Market
Pandemic testing has become the new norm. “We’ve gone from 1 million to 4.5 million tests per week in the
Read more
New Vaccine from Johnson & Johnson a Game-Changer
The fight against the health pandemic continues. We already have vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), and Moderna Inc. (NASDAQ:MRNA). Johnson & Johnson’s (NYSE:JNJ) vaccine is reportedly effective,
Read more
Cannabis Reform Could Get a Major Boost
As legal cannabis goes mainstream, it’s finding its way into a good deal of medical, beauty, and even recreational products.
Read more
Probiotics a $64.02 Billion Opportunity
The probiotics market could become a $64.02 billion market by 2022. All thanks to growing consumer awareness of its benefits,
Read more
Psilocybin Could Help Treat Obesity
Psilocybin may not be legal for most of the U.S., but that could change. All thanks to mounting evidence that
Read more
This is Why Gene Editing Stocks are Rising
Gene editing stocks are skyrocketing. While it’s not clear why, it may be thanks in part to Ark Investment Management
Read more
This is Why Inovio Pharmaceuticals Was Crushed
Shares of Inovio Pharmaceuticals (INO) were crushed earlier this week. All after the US FDA just placed its Phase 2/3
Read more
A Clear Sign Telehealth Demand is Here to Stay
With or without the pandemic, telehealth is here to stay, revolutionizing healthcare as we know it. According to a recent
Read more